184098-07-5

Upstream product

• 400-93-1 3-nitro-4-fluoroacetophenone 
• 591-19-5 m-Bromoaniline 

Downstream Products

• 184098-08-6 1-(1-(3-bromophenyl)-1H-benzo[d]imidazol-5-yl)ethanone 
• 1287739-05-2 1-(1-(3-bromophenyl)-1H-benzo[d]imidazol-5-yl)-2,2,2-d3-ethanone 
• 1287739-10-9 2-(1-(3-bromophenyl)-1H-benzo[d]imidazol-5-yl)propan-d6-2-ol 
• 1287738-78-6 3'-(5-(2-hydroxy-1,1,1,3,3,3-d6-propan-2-yl)-1H-benzo[d]imidazol-1-yl)biphenyl-2-carbonitrile 
• 184220-52-8 1-[3-amino-4-(3-bromo-phenylamino)-phenyl]-ethanone 

Relevant academic research and scientific papers

SUBSITITUTED BENZIMIDAZOLES

This invention relates to novel substituted benzimidazoles and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a compound that modulates theGABAA receptor. This invention also provides novel intermediates for the preparation of the compounds of the invention, and salts thereof.

BENZIMIDAZOLE DERIVATIVES AND THEIR USE FOR MODULATING THE GABAA RECEPTOR COMPLEX

This invention relates to novel benzimidazole derivatives of formula (I), pharmaceutical compositions containing these compounds, and methods of treatment therewith. The compounds of the invention are useful in the treatment of central nervous system dise

BENZIMIDAZOLE DERIVATIVES AND THEIR USE FOR MODULATING THE GABA-A RECEPTOR COMPLEX

This invention relates to novel benzimidazole derivatives, pharmaceutical compositions containing these compounds, and methods of treatment therewith. The compounds of the invention are useful in the treatment of central nervous system diseases and disord